Study of suspected Guillain-Barré syndrome cases
Part of Brain & nervous system, Immune system & allergy clinical trials.
This is an observational study that looks at people who were suspected to have Guillain-Barré syndrome and were cared for at University Hospital of Basel in the past. It does not test a new treatment—researchers review existing care to learn more about this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a suspected diagnosis of Guillain-Barré syndrome
- You were treated at University Hospital of Basel between Jan 1, 2005 and Feb 28, 2021
- You did not refuse the study consent in general
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called efgartigimod for people with Guillain-Barré syndrome (GBS), a condition where the immune system attacks the nerves. The medicine aims to reduce the immune attack and help you recover faster. It is for people who started having GBS symptoms within the last 2 weeks and have moderate to severe symptoms.
This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.
This study tests a new investigational medicine called empasiprubart when added to the standard IVIg treatment for people with Guillain-Barré syndrome. It aims to see if adding this medicine can help improve recovery compared to IVIg alone.
This study uses a new light-based imaging technique to look at nerve inflammation and damage in people with Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP). It may help doctors better understand and monitor these conditions.
This study tests whether immunoadsorption works as well as plasma exchange to improve symptoms in people with Guillain-Barré syndrome. The goal is to find which treatment helps recovery and is safer for patients.
This study examines patients who came to the emergency department with sudden neurological symptoms like weakness, numbness, speech problems, dizziness, or seizures. Researchers will review medical records to better understand how these conditions are diagnosed and what happens to patients over time.
Hear when a new Guillain-Barre Syndrome (GBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.